DCE-MRI for Early Prediction of Response in Advanced Hepatocellular Carcinoma after TACE and Sorafenib Therapy
نویسندگان
چکیده
Selective internal radiation therapy (SIRT) with Yttrium-90 (Y90) microspheres is a promising therapy option in patients with advanced hepatocellular carcinoma (HCC). Early detection of therapy response is warranted to ensure adequate ongoing treatment, but size measurements and contrast enhancement are often not conclusive. We aimed to evaluate diffusion weighted imaging (DWI) for early prediction of tumor response in patients with HCC following SIRT.
منابع مشابه
Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib
AIM To identify clinical biomarkers that could early predict improved survival in patients with advanced-stage hepatocellular carcinoma (HCC) treated with transarterial chemoembolization combined with sorafenib (TACE-S). METHODS We retrospectively evaluated the medical records of consecutive patients with advanced-stage HCC who underwent TACE-S from January 2012 to December 2015. At the first...
متن کامل“ TACE with drug - eluting beads is a safe treatment option ” In patients with advanced hepatocellular
The study, published in the Journal of Vascular and Interventional Radiology, was focused on investigating TACE with drug-eluting beads (Biocompatibles) in patients with Barcelona Clinic Liver Cancer (BCLC) C stage hepatocellular carcinoma. The recommended treatment for advanced stage hepatocellular carcinoma was systemic therapy. The authors noted that, until the SHARP (Sorafenib hepatocellula...
متن کاملTransarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis
BACKGROUND Sorafenib is used in patients with intermediate or advanced stage hepatocellular carcinoma (HCC) before or after of transarterial chemoembolization (TACE). However, the survival outcomes of TACE combined with sorafenib versus TACE alone remain controversial. Thus, we conducted a meta-analysis to evaluate the efficacy and safety of the combination therapy of TACE plus sorafenib in pat...
متن کاملValidation of the criteria of transcatheter arterial chemoembolization failure or refractoriness in patients with advanced hepatocellular carcinoma proposed by the LCSGJ.
BACKGROUND Transcatheter arterial chemoembolization (TACE) failure or refractoriness is an indication for sorafenib therapy in patients with advanced hepatocellular carcinoma. The study evaluated the validity of the definition of TACE failure or refractoriness as proposed by the Liver Cancer Study Group of Japan (LCSGJ) through a retrospective analysis of sorafenib treatment. METHODS Out of 2...
متن کاملTranscatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma
Targeted therapy is currently the standard treatment for advanced hepatocellular carcinoma (HCC), but an effective treatment after the discontinuation of sorafenib therapy remains uncertain. We aim to investigate the survival benefits of transcatheter arterial chemoembolization (TACE) after stopping sorafenib therapy. We retrospectively analyzed all patients with advanced HCC, who had received ...
متن کامل